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Background
Anhedonia is recognized as one of the core symptoms of
depression but it is also seen in other mental disorders.
Cognitive-Analytic Therapy (CAT) is a type of brief psy-
chotherapy which has been proven efficacious for patients
with various psychiatric diagnoses. The present study aims
to: 1) Investigate the presence of anhedonia in patients
with borderline personality disorder (BPD) 2) Evaluate
the CAT outcome on anhedonia, depression and anxiety
of these patients.
Materials and methods
The sample of the study consisted of 57 patients, who
attended the Mental Health Center of N/W district of
Thessaloniki and received a diagnosis of BPD or personal-
ity disorder NOS with predominant borderline personal-
ity traits according to DSM-IV criteria. These patients
completed a 16-sessions of CAT and attended a 2-month
follow up. The Beck Depression Inventory (BDI) and the
State-Trait Anxiety Inventory (STAI) were used as evalua-
tion instruments both at the intake and at the follow up
time. Anhedonia was tested by the relevant question of
BDI.
Results
At the 2-month follow-up, the patients showed a statisti-
cally significant improvement on BDI total score, on the
anhedonia sub-scale score, as well as on the state and trait
scores of the STAI, compared to the intake (p<0.001). Fur-
thermore, significantly fewer patients were still anhedonic
(18/39 vs 50/57, x2=37.32, p<0.001) in comparison to
pre-therapy evaluation. Finally, patients with BDP only
(N=21) and those with BDP and an additional axis-I diag-
nosis, except a depressive disorder (N=11) had a lower
score on anhedonia compared to BDP patients with an
additional depressive disorder (N=25). However, the dif-
ference showed only a tendency for statistical significance
(p<0.1).
Conclusions
CAT is an effective psychotherapeutic approach in reduc-
ing anhedonia in patients with BDP. The improvement of
anhedonia comes into the line with the amelioration of
anxiety and depressive symptoms. Anhedonia is a core
symptom of a depressive disorder but it is also seen, not
infrequently, in patients BDP
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